A Mechanistic Site-Of-Action Model: A Tool for Informing Right Target, Right Compound, And Right Dose for Therapeutic Antagonistic Antibody Programs
Quantitative modeling is increasingly utilized in the drug discovery and development process, from the initial stages of target selection, through clinical studies. The modeling can provide guidance on three major questions–is this the right target, what are the right compound properties, and what i...
Main Authors: | Georgi I. Kapitanov, Jeffrey R. Chabot, Jatin Narula, Mahua Roy, Hendrik Neubert, Joe Palandra, Vahid Farrokhi, Jay S. Johnson, Robert Webster, Hannah M. Jones |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Bioinformatics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbinf.2021.731340/full |
Similar Items
-
STRATEGI PEMASARAN INDUSTRI MADU PADA PT MADU PRAMUKA DI KABUPATEN BATANG
by: Eka Pratiwi, et al.
Published: (2017-09-01) -
Pharmacokinetic/Pharmacodynamic Profiles of Tiamulin in an Experimental Intratracheal Infection Model of Mycoplasma gallisepticum
by: Xia Xiao, et al.
Published: (2016-09-01) -
Pharmacometric Modeling in Rheumatoid Arthritis
by: Lacroix, Brigitte
Published: (2015) -
Model-Based Biomarker Selection for Dose Individualization of Tyrosine-Kinase Inhibitors
by: Maddalena Centanni, et al.
Published: (2020-03-01) -
In vivo and in silico characterization of apocynin in reducing organ oxidative stress: A pharmacokinetic and pharmacodynamic study
by: Fangfei Liu, et al.
Published: (2020-08-01)